檢索結果 - JF Forbes

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial

    Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial 由 Jack Cuzick, JF Forbes, Ivana Šestak, Simon Cawthorn, H. Hamed, K Holli, Anthony Howell

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS‐II DCIS)

    Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS‐II DCIS) 由 Ilona Juraskova, Phyllis Butow, Angeles Lopez, M Seccombe, Alan S. Coates, F Boyle, Nicole McCarthy, Linda Reaby, JF Forbes

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial

    Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe li... 由 AW Bradbury, D.J. Adam, Jocelyn Bell, JF Forbes, F. G. R. Fowkes, Iain Gillespie, Gillian Raab, CV Ruckley

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

    Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 由 Manuela Rabaglio, Zijie Sun, Karen N. Price, Monica Castiglione‐Gertsch, Hanne Hawle, Beat Thürlimann, Henning T. Mouridsen, Mario Campone, JF Forbes, Robert Paridaens, Marco Colleoni, Tadeusz Pieńkowski, Jean‐Marie Nogaret, István Láng, Ian Smith, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

    Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial 由 Giuseppe Viale, MM Regan, Patrizia DellʼOrto, Mauro G. Mastropasqua, Eugenio Maiorano, Blake B. Rasmussen, Gaëtan MacGrogan, JF Forbes, Robert Paridaens, Marco Colleoni, István Láng, Beat Thürlimann, Henning T. Mouridsen, L. Mauriac, RD Gelber, K.N. Price, Aron Goldhirsch, B A Gusterson, Coates As

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: